132 related articles for article (PubMed ID: 18271927)
1. Etiologic value of p53 mutation spectra and differences with histology in lung cancers.
Shimmyo T; Okada A; Hashimoto T; Kobayashi Y; Miyagi Y; Ishikawa Y; Nakagawa K; Osada H; Tsuchiya E
Cancer Sci; 2008 Feb; 99(2):287-95. PubMed ID: 18271927
[TBL] [Abstract][Full Text] [Related]
2. Different subtypes of human lung adenocarcinoma caused by different etiological factors. Evidence from p53 mutational spectra.
Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Nakagawa K; Hayashi J; Tsuchiya E
Am J Pathol; 2000 Dec; 157(6):2133-41. PubMed ID: 11106585
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of p53 and K-ras in lung carcinomas of coal miners.
Sarkar FH; Li Y; Vallyathan V
Int J Mol Med; 2001 Oct; 8(4):453-9. PubMed ID: 11562787
[TBL] [Abstract][Full Text] [Related]
4. Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: unique spectra involving G to A transitions and G to T transversions in both histologic types.
Gao WM; Mady HH; Yu GY; Siegfried JM; Luketich JD; Melhem MF; Keohavong P
Lung Cancer; 2003 May; 40(2):141-50. PubMed ID: 12711114
[TBL] [Abstract][Full Text] [Related]
5. p53 mutation spectra for squamous cell carcinomas at different levels of human bronchial branches.
Shimmyo T; Hashimoto T; Kobayashi Y; Miyagi Y; Ishikawa Y; Nakagawa K; Osada H; Tsuchiya E
Int J Cancer; 2006 Aug; 119(3):501-7. PubMed ID: 16506220
[TBL] [Abstract][Full Text] [Related]
6. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H
Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569
[TBL] [Abstract][Full Text] [Related]
7. Relationship between TP53 tumour suppressor gene mutations and smoking-related bulky DNA adducts in a lung cancer study population from Hungary.
Anna L; Holmila R; Kovács K; Gyorffy E; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Husgafvel-Pursiainen K; Schoket B
Mutagenesis; 2009 Nov; 24(6):475-80. PubMed ID: 19643813
[TBL] [Abstract][Full Text] [Related]
8. p53 mutational spectra are different between squamous-cell carcinomas of the lip and the oral cavity.
Ostwald C; Gogacz P; Hillmann T; Schweder J; Gundlach K; Kundt G; Barten M
Int J Cancer; 2000 Oct; 88(1):82-6. PubMed ID: 10962443
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity is related to p53 mutations and smoking in lung cancer.
Zienolddiny S; Ryberg D; Arab MO; Skaug V; Haugen A
Br J Cancer; 2001 Jan; 84(2):226-31. PubMed ID: 11161381
[TBL] [Abstract][Full Text] [Related]
10. Distribution of p53 and K-ras mutations in human lung cancer tissues.
Gao HG; Chen JK; Stewart J; Song B; Rayappa C; Whong WZ; Ong T
Carcinogenesis; 1997 Mar; 18(3):473-8. PubMed ID: 9067544
[TBL] [Abstract][Full Text] [Related]
11. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
[TBL] [Abstract][Full Text] [Related]
12. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
13. The TP53 gene, tobacco exposure, and lung cancer.
Toyooka S; Tsuda T; Gazdar AF
Hum Mutat; 2003 Mar; 21(3):229-39. PubMed ID: 12619108
[TBL] [Abstract][Full Text] [Related]
14. Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.
Jarmalaite S; Kannio A; Anttila S; Lazutka JR; Husgafvel-Pursiainen K
Int J Cancer; 2003 Oct; 106(6):913-8. PubMed ID: 12918069
[TBL] [Abstract][Full Text] [Related]
15. On the origin of p53 G:C --> T:A transversions in lung cancers.
Rodin SN; Rodin AS
Mutat Res; 2002 Oct; 508(1-2):1-19. PubMed ID: 12379456
[TBL] [Abstract][Full Text] [Related]
16. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers.
Le Calvez F; Mukeria A; Hunt JD; Kelm O; Hung RJ; Tanière P; Brennan P; Boffetta P; Zaridze DG; Hainaut P
Cancer Res; 2005 Jun; 65(12):5076-83. PubMed ID: 15958551
[TBL] [Abstract][Full Text] [Related]
17. Influence of common XPD and XRCC1 variant alleles on p53 mutations in lung tumors.
Hou SM; Ryk C; Kannio A; Angelini S; Fält S; Nyberg F; Husgafvel-Pursiainen K
Environ Mol Mutagen; 2003; 41(1):37-42. PubMed ID: 12552590
[TBL] [Abstract][Full Text] [Related]
18. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
19. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra.
Olshan AF; Weissler MC; Pei H; Conway K
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):499-504. PubMed ID: 9232336
[TBL] [Abstract][Full Text] [Related]
20. p53 mutations and occupational exposures in a surgical series of lung cancers.
Harty LC; Guinee DG; Travis WD; Bennett WP; Jett J; Colby TV; Tazelaar H; Trastek V; Pairolero P; Liotta LA; Harris CC; Caporaso NE
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):997-1003. PubMed ID: 8959323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]